Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wouter Ouwerkerk

Showing results (81-90 of 97) with videos related to

Pageof 10
Sort By:
JACC. Asia|March 6, 2023
Incidence, Clinical Correlates, and Prognostic Impact of Dementia in Heart Failure: A Population-Based Cohort StudyQing-Wen Ren, Tiew-Hwa Katherine Teng, Yi-Kei Tse, et al.
Heart (British Cardiac Society)|April 1, 2021
Telomere length is independently associated with all-cause mortality in chronic heart failureSimon P R Romaine, Matthew Denniff, Veryan Codd, et al.
European Journal of Heart Failure|May 16, 2019
The clinical significance of interleukin-6 in heart failure: results from the BIOSTAT-CHF studyGeorge Markousis-Mavrogenis, Jasper Tromp, Wouter Ouwerkerk, et al.
European Journal of Heart Failure|June 26, 2020
Effects of combined renin-angiotensin-aldosterone system inhibitor and beta-blocker treatment on outcomes in heart failure with reduced ejection fraction: insights from BIOSTAT-CHF and ASIAN-HF registriesWouter Ouwerkerk, Tiew-Hwa K Teng, Jasper Tromp, et al.
European Journal of Heart Failure|November 13, 2019
Concentric vs. eccentric remodelling in heart failure with reduced ejection fraction: clinical characteristics, pathophysiology and response to treatmentJan F Nauta, Yoran M Hummel, Jasper Tromp, et al.
International Journal of Cardiology|January 8, 2018
Fibroblast growth factor 23 is related to profiles indicating volume overload, poor therapy optimization and prognosis in patients with new-onset and worsening heart failureJozine M Ter Maaten, Adriaan A Voors, Kevin Damman, et al.
European Journal of Heart Failure|February 5, 2024
Distinguishing heart failure with reduced ejection fraction from heart failure with preserved ejection fraction: A phenomics approachBart J van Essen, Ganash N Tharshana, Wouter Ouwerkerk, et al.
Lancet (London, England)|August 27, 2019
Identifying optimal doses of heart failure medications in men compared with women: a prospective, observational, cohort studyBernadet T Santema, Wouter Ouwerkerk, Jasper Tromp, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|July 11, 2025
Less Symptom Improvement in Patients Undergoing TAVI With Concomitant COPD, Atrial Fibrillation and Heart FailureKees H van Bergeijk, Constantijn S Venema, Bob Ophuis, et al.
JAAD International|November 17, 2022
Comparison of real-world treatment outcomes of systemic immunomodulating therapy in atopic dermatitis patients with dark and light skin typesAngela L Bosma, Wouter Ouwerkerk, Madeline J Heidema, et al.
Pageof 10

Showing results (81-90 of 97) with videos related to

Sort By:
Pageof 10
JACC. Asia|March 6, 2023
Incidence, Clinical Correlates, and Prognostic Impact of Dementia in Heart Failure: A Population-Based Cohort StudyQing-Wen Ren, Tiew-Hwa Katherine Teng, Yi-Kei Tse, et al.
Heart (British Cardiac Society)|April 1, 2021
Telomere length is independently associated with all-cause mortality in chronic heart failureSimon P R Romaine, Matthew Denniff, Veryan Codd, et al.
European Journal of Heart Failure|May 16, 2019
The clinical significance of interleukin-6 in heart failure: results from the BIOSTAT-CHF studyGeorge Markousis-Mavrogenis, Jasper Tromp, Wouter Ouwerkerk, et al.
European Journal of Heart Failure|June 26, 2020
Effects of combined renin-angiotensin-aldosterone system inhibitor and beta-blocker treatment on outcomes in heart failure with reduced ejection fraction: insights from BIOSTAT-CHF and ASIAN-HF registriesWouter Ouwerkerk, Tiew-Hwa K Teng, Jasper Tromp, et al.
European Journal of Heart Failure|November 13, 2019
Concentric vs. eccentric remodelling in heart failure with reduced ejection fraction: clinical characteristics, pathophysiology and response to treatmentJan F Nauta, Yoran M Hummel, Jasper Tromp, et al.
International Journal of Cardiology|January 8, 2018
Fibroblast growth factor 23 is related to profiles indicating volume overload, poor therapy optimization and prognosis in patients with new-onset and worsening heart failureJozine M Ter Maaten, Adriaan A Voors, Kevin Damman, et al.
European Journal of Heart Failure|February 5, 2024
Distinguishing heart failure with reduced ejection fraction from heart failure with preserved ejection fraction: A phenomics approachBart J van Essen, Ganash N Tharshana, Wouter Ouwerkerk, et al.
Lancet (London, England)|August 27, 2019
Identifying optimal doses of heart failure medications in men compared with women: a prospective, observational, cohort studyBernadet T Santema, Wouter Ouwerkerk, Jasper Tromp, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|July 11, 2025
Less Symptom Improvement in Patients Undergoing TAVI With Concomitant COPD, Atrial Fibrillation and Heart FailureKees H van Bergeijk, Constantijn S Venema, Bob Ophuis, et al.
JAAD International|November 17, 2022
Comparison of real-world treatment outcomes of systemic immunomodulating therapy in atopic dermatitis patients with dark and light skin typesAngela L Bosma, Wouter Ouwerkerk, Madeline J Heidema, et al.
Pageof 10